David White

Hemispherx and Antigenics' Vaccine Adjuvants: Indispensable for Vaccines

I should also have added that HEB has a whole slew of other uses for ampligen, including the use as a flu vaccine adjuvant. It will take money to prove all of these out. Still these applications do hold incredible future promise for HEB earnings. HEB does have something to do with the money they will derive from the mixed shelf registration. Of course, sometimes HEB does get "free" help such as the case above in which the Japanese Institute of Health is spearheading the research into ampligen use with flu vaccine.

Hemispherx and Antigenics' Vaccine Adjuvants: Indispensable for Vaccines

I should have added that Barrons has done exposes on Jim Cramer's accuracy. They claim he makes more bad calls than good ones. I tend to think this is one of his bad ones.

In fairness I should add that I consider Jim Cramer to be educational. He does say a lot of good things. I just done agree with him on this.

Hemispherx and Antigenics' Vaccine Adjuvants: Indispensable for Vaccines

Today HEB is down strongly again. This is almost getting to be a trend. Apparently Jim Cramer has been bad mouthing the stock. Admittedly they did file a $150M mixed shelf offering recently. This should cuase significant dilution of the stock. It will cause much less if the stock goes up on approval. Also it is a mixed shelf offering. HEB may be able to sell bonds soon if FDA approval comes through.The data presented in this article favor approval of ampligen for CFS, even though the flu virus work is not directly applicable. The FDA scientists are very bureaucratic. Ampligen has been proven to be at least reasonably effective against CFS. It does not seem to be unsafe. The only really valid reason for rejecting the NDA now is safety. What bureaucrat would want to be on record as rejecting as unsafe an orphan drug that is at least reasonable effective against CFS, when half the world may soon be taking ampligen to help fight off flu?